Vitamins and Minerals for Children With Downs Syndrome
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The trial aimed to examine the effects of supplementation with antioxidants and folinic acid on the health, growth and psychomotor development of children with Down syndrome. 156 children with Trisomy 21, less than 7 months of age were recruited and randomised into four groups to receive antioxidants, folinic acid, a combination of antioxidants and folinic acid or a placebo. Blinded outcome assessment was carried out 18 months later.Blood and urine samples were also taken around 12 months of age to examine metabolic effects of supplementation.
Condition or disease
Trisiomy 21 (Down Syndrome)
Drug: Antioxidants- (Vitamins A,C,E Selenium and Zinc)Drug: Folinic acidDrug: Vitamins A,C,E Selenium and Zinc and Folinic acid.Drug: Placebo
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
up to 7 Months (Child)
Sexes Eligible for Study:
Under 7 months of age
Live in recruitment Area-i.e. London inside M25, in West Midlands or SW England.